What is Biodapt?
Biodapt Inc. is dedicated to the design, manufacturing, and distribution of specialized lower limb prosthetic components. Their product line, featuring innovations like the MOTO KNEE 2 and various prosthetic feet, is engineered to offer amputees unparalleled quality and versatility, enabling participation in demanding activities such as action sports. The company caters to a diverse clientele, ranging from elite adaptive athletes competing at the highest levels to individuals seeking to maintain an active lifestyle. BioDapt's core mission is to enhance the capabilities and experiences of its users through cutting-edge prosthetic technology.
How much funding has Biodapt raised?
Biodapt has raised a total of $15K across 1 funding round:
Debt
$15K
Debt (2021): $15K with participation from PPP
What's next for Biodapt?
Positioned at a Series A/B growth stage, Biodapt's recent capital injection is poised to accelerate its strategic objectives. This funding will likely support enhanced research and development for next-generation prosthetic technologies, expansion of manufacturing capabilities to meet growing demand, and broader market penetration within the action sports and adaptive athletics sectors. The company's focus on innovation and user-centric design suggests a trajectory aimed at solidifying its leadership in specialized prosthetic solutions.
See full Biodapt company page
